Syndax Pharmaceuticals (SNDX) Institutional Ownership

Of the 201 institutional investors that purchased Syndax Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($9.02M), Bank of America Corp DE ($5.01M), Elmind Capital LP ($3.71M), Soleus Capital Management L.P. ($1.91M), Assenagon Asset Management S.A. ($1.64M), Eventide Asset Management LLC ($1.27M), and Vanguard Group Inc. ($1.20M).

Institutional investors have bought a total of 33,445,874 shares in the last 24 months. This purchase volume represents approximately $703.64M in transactions.

Of the 67 institutional investors that sold Syndax Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Assenagon Asset Management S.A. ($2.00M), Granahan Investment Management LLC ($685.07K), Bank of America Corp DE ($602.03K), Eversept Partners LP ($581.69K), Millennium Management LLC ($552.16K), Dimensional Fund Advisors LP ($459.34K), and Catalio Capital Management LP ($417.91K).

Institutional investors have sold a total of 9,736,594 shares in the last 24 months. This volume of shares sold represents approximately $184.25M in transactions.